E1	Procedure:T1 Name:T2
E3	Procedure:T3 Name:T4
E5	Procedure:T5 Name:T6
E7	Procedure:T7 Name:T8
E11	Condition:T11 Name:T12
E13	Condition:T13 Name:T14
E14	Eq-Comparison:T20 Operator:T16 Value:T17 Value2:T18
E2	Condition:T21 Name:T22
E4	Modifier:T23 Modifies:T22
E6	Modifier:T24 Modifies:T22
E9	Assertion:T26 Asserted:E2
E10	Procedure:T27 Name:T28 Temporality:E15
E12	Condition:T29 Name:T30
E15	Eq-Comparison:T31 Temporal-Recency:T32
E17	Drug:T34 Name:T35
E20	Age:T38 Numeric-Filter:E14
E21	Condition:T39 Name:T40
E22	Procedure:T41 Name:T42
E25	Drug:T45 Name:T46
E26	Condition:T48 Name:T49 Temporality:E27
E27	Eq-Comparison:T50 Temporal-Period:T51
E28	Condition:T52 Name:T53
E29	Assertion:T54 Asserted:E28
E31	Modifier:T56 Modifies:T14
E32	Modifier:T57 Modifies:T14
E34	Procedure:T15 Name:T59
E35	Contraindication:T60 Contraindicates:E34
E36	Procedure:T61 Name:T62
E37	Procedure:T63 Name:T64
E38	Eq-Comparison:T65 Temporal-Period:T66
E39	Condition:T67 Name:T68 Temporality:E38
E40	Drug:T19 
E41	Drug:T69 Name:T70
T1	Procedure 107 130	external beam radiation
T2	Procedure-Name 107 130	external beam radiation
T3	Procedure 140 152	chemotherapy
T4	Procedure-Name 140 152	chemotherapy
T5	Procedure 287 310	external beam radiation
T6	Procedure-Name 287 310	external beam radiation
T7	Procedure 319 331	chemotherapy
T8	Procedure-Name 319 331	chemotherapy
T9	Life-Stage-And-Gender 186 192	female
T10	Life-Stage-And-Gender 177 181	Male
T11	Condition 381 395	breast feeding
T12	Condition-Name 381 395	breast feeding
T13	Condition 455 466	dysfunction
T14	Condition-Name 455 466	dysfunction
T16	Eq-Operator 206 208	to
T17	Eq-Value 203 205	18
T18	Eq-Value 209 211	70
T20	Eq-Comparison 203 211	18 to 70
T21	Condition 70 77	gliomas
T22	Condition-Name 70 77	gliomas
T23	Modifier 60 69	recurrent
T24	Modifier 48 56	residual
T26	Assertion 34 47	evaluated for
T27	Procedure 98 105	surgery
T28	Procedure-Name 98 105	surgery
T29	Condition 92 97	tumor
T30	Condition-Name 92 97	tumor
T31	Eq-Comparison 84 91	initial
T32	Eq-Temporal-Recency 84 91	initial
T34	Drug 158 170	temozolamide
T35	Drug-Name 158 170	temozolamide
T38	Age 198 202	Ages
T39	Condition 260 266	glioma
T40	Condition-Name 260 266	glioma
T41	Procedure 278 285	surgery
T42	Procedure-Name 278 285	surgery
T45	Drug 337 349	temozolamide
T46	Drug-Name 337 349	temozolamide
T47	Life-Stage-And-Gender 356 361	Women
T48	Condition 371 379	pregnant
T49	Condition-Name 371 379	pregnant
T50	Eq-Comparison 366 370	were
T51	Eq-Temporal-Period 366 370	were
T52	Condition 409 417	pregnant
T53	Condition-Name 409 417	pregnant
T54	Assertion 400 408	possibly
T56	Modifier 449 454	renal
T57	Modifier 438 445	hepatic
T15	Procedure 487 490	MRI
T59	Procedure-Name 487 490	MRI
T60	Contraindication 491 508	contraindications
T61	Procedure 515 525	pacemakers
T62	Procedure-Name 515 525	pacemakers
T63	Procedure 527 552	non-MR compatible devices
T64	Procedure-Name 527 552	non-MR compatible devices
T65	Eq-Comparison 576 583	history
T66	Eq-Temporal-Period 576 583	history
T67	Condition 592 608	hypersensitivity
T68	Condition-Name 592 608	hypersensitivity
T19	Drug 587 591	drug
T69	Drug 612 628	18F-Fluciclovine
T70	Drug-Name 612 628	18F-Fluciclovine
A1	Life-Stage-And-Gender-Type T9 female
A2	Life-Stage-And-Gender-Type T10 male
A3	Eq-Operator-Value T16 BETWEEN
A4	Assertion-Type-Value E9 hypothetical
A5	Eq-Temporal-Recency-Value T32 first-time
A8	Life-Stage-And-Gender-Type T47 female
A9	Eq-Temporal-Period-Value T51 past
A10	Assertion-Type-Value E29 possible
A11	Eq-Temporal-Period-Value T66 past
R1	Treatment-For Arg1:E10 Arg2:E12
R2	Using Arg1:E3 Arg2:E17
R3	Using Arg1:E7 Arg2:E25
R4	If-Then Arg1:T47 Arg2:E26
R5	Example-Of Arg1:E36 Arg2:E35
R6	Example-Of Arg1:E37 Arg2:E35
R7	Caused-By Arg1:E39 Arg2:E40
R8	Caused-By Arg1:E39 Arg2:E41
R9	Or Arg1:E6 Arg2:E4
R10	After Arg1:E2 Arg2:E10
R11	Or Arg1:E1 Arg2:E3
R12	Or Arg1:T10 Arg2:T9
R13	Before Arg1:E21 Arg2:E22
R14	Or Arg1:E5 Arg2:E7
R15	Or Arg1:E11 Arg2:E29
R16	Or Arg1:E32 Arg2:E31
R17	Or Arg1:E10 Arg2:E1
R18	Or Arg1:E22 Arg2:E5
R19	Or Arg1:E26 Arg2:E11
R20	Or Arg1:E36 Arg2:E37
